This article originally published by Texas Medical Center – January 30, 2024
TMC Innovation Announces 2024 Accelerator for Cancer Therapeutics Cohort
Texas Medical Center Innovation (TMCi) announced its 2024 Accelerator for Cancer Therapeutics annual cohort comprised of Texas-based innovators working on small molecule, antibody and cell therapy technologies. In its fourth year, the Accelerator for Cancer Therapeutics continues to attract the latest advancements in cancer therapeutics by mentoring inventors and startups looking to bring novel cancer therapies from early drug discovery to the next business milestone.
Two researchers from the Texas A&M School of Pharmacy are among the selected participants: Dr. Narendra Kumar and Dr. Jayshree Mishra.
